Peroxisome proliferator-activated receptor agonist tablets prescribed in cardiology and endocrinology for dyslipidemia and type 2 diabetes. Acquired by specialized clinics from drug manufacturers for dual therapy in metabolic syndrome patients in hospital and outpatient settings.